2seventybio
2seventy bio, formerly Genetix and a Regeneron company, is developing innovative gene therapies for severe genetic disorders.

Year Established: 2021
Stock Ticker: REGN
Exchange: NASDAQ
2seventy bio, formerly Genetix and a Regeneron company, is developing innovative gene therapies for severe genetic disorders.
2seventy bio, formerly Genetix and a Regeneron company, is developing innovative gene therapies for severe genetic disorders.
2seventy bio, formerly Genetix and a Regeneron company, is developing innovative gene therapies for severe genetic disorders.